Showing results (41-50 of 905) with videos related to
Sort By:
Pageof 91
Hypertension (Dallas, Tex. : 1979)|May 29, 2025
Are Diuretics a Clandestine Risk Factor for Patients With Treatment-Resistant Hypertension?Bertram Pitt, Christopher S WilcoxJournal of Cardiovascular Pharmacology|December 5, 2020
Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?Christopher S Wilcox, Bertram PittHypertension (Dallas, Tex. : 1979)|June 2, 2026
Management of Diuretic Induced Hypokalemia in Elderly HypertensivesBertram Pitt, Christopher S WilcoxEuropean Journal of Heart Failure|July 22, 2022
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failureMuthiah Vaduganathan, João Pedro Ferreira, Patrick Rossignol, et al.Circulation. Heart Failure|October 18, 2015
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction databaseSonya K Hui, Abhinav Sharma, Kieran Docherty, et al.European Journal of Heart Failure|September 3, 2019
Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failureStefano Coiro, Nicolas Girerd, Abhinav Sharma, et al.The American Journal of Cardiology|May 16, 2006
Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarctionBarry Greenberg, Faiez Zannad, Bertram PittExpert Opinion on Investigational Drugs|October 1, 2021
An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertensionBertram Pitt, Frederic Jaisser, George BakrisClinical Trials (London, England)|November 18, 2018
Beware of on-treatment safety analysesFred Yang, Janet Wittes, Bertram PittPageof 91